CPHI Online is the largest global marketplace in the pharma ingredients industry

  • Products
    0
  • Companies
    0
  • Articles
    0
  • Events
    0
  • Webinars
    0

Disposable pens: tailor the injection

Disposable pens: tailor the injection
Product Description

Our portfolio of disposable pens includes variable and fixed dose devices for automatic and manual drug administration, combining modern design with high intuitiveness of use for multidose therapies. Nemera offers three disposable pen injector development platforms with wide customization and drug capability options, to serve fulfilling of various customer requirements: PENONE – Dedicated to manufacturing of disposable, fixed-dose and fixed number of increments pen injectors. PENVARIO – Dedicated to manufacturing of disposable, variable-dose pen injectors PENHV – Dedicated to manufacturing of disposable, spring-driven pen injectors for the high dose / high viscosity drugs

Nemera

  • FR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

Nemera

  • FR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

More Products from Nemera (25)

  • Sof’Airless XS+

    Product Sof’Airless XS+

    Sof’Airless XS+ is a protective mini-airless system for small dose applications and sampling.
    It is the solution for trial sizes or local treatments with very little skin surface to cover.
    It targets Rx and OTC dermal gels and creams and is already used for cold sore treatments.
  • Oral, Vaginal, Rectal

    Product Oral, Vaginal, Rectal

    We offer millimeter solutions in medicine applicators and dispensers, being today a global reference for quality and precision in this segment.
    Our systems aim to be used for oral, vaginal and rectal treatments such as Oral infections, Vaginal infections, and Rectal diseases.
  • RetroNose®: the pMDI concept device targeting nasal drug delivery through oral administration

    Product RetroNose®: the pMDI concept device targeting nasal drug delivery through oral administration

    With RetroNose®, enhance therapeutic efficacy of your nasal drug with a better deposition
  • Safe'n'Spray™: the smart electronic concept device with locking features

    Product Safe'n'Spray™: the smart electronic concept device with locking features

    Safe'n'Spray™: the integrated device with reusable electronic locking unit and fingerprint identification, to monitor drug delivered and prevent overdosing. Normal 0 21 false false false FR X-NONE X-NONE ...
  • Smart wearable to improve patients’ life.

    Product Smart wearable to improve patients’ life.

    Symbioze smart wearable platform is an innovative, large-volume on-body injector to foster patient’s adherence. It offers a great combination between design robustness, ease of use, connectivity, and sustainability, for a seamless and enhanced injection experience.
  • A spray for vaccine administration through the nasal route

    Product A spray for vaccine administration through the nasal route

    With our extensive experience in intranasal delivery, we offer reliable, easy to use and safe nasal vaccine solutions*. The concept device is constituted with a nozzle, a dose divider, and a luer lock syringe. It contains two-doses, allowing vaccine delivery for each nostril.
  • Implanters: Solutions for sustained released formulations

    Product Implanters: Solutions for sustained released formulations

    Implants are fragile and insertion into the body requires caution. Nemera developed a portfolio of devices to deliver implants with integrated needlestick protection. As implants can vary a lot, we support your projects and explore design attributes that will increase the user experience such as improved h...
  • Reusable pens: multiple use, same efficiency

    Product Reusable pens: multiple use, same efficiency

    Ergonomic, market-proven reusable pen injectors Our spring-assisted reusable pens lower the force necessary to administer the dose for patient’s ease-of-use. Thanks to its ergonomic design, patients can easily reach the trigger button for an enhanced injection experience. This platform offers a high range ...
  • Safe’n’Spray(TM): Managing drug overdosing easily with a smart electronic concept device

    Product Safe’n’Spray(TM): Managing drug overdosing easily with a smart electronic concept device

    Safe'n'Spray: the smart electronic concept device with locking features Some drugs such as strong painkillers called opioids (e.g. Fentanyl) can cause respiratory depression in case of overdose, and can be fatal. That’s why patients must rely on a device with locking and child-resistant features for multid...
  • Sof’Bag®+ protects the formulation and delivers it on a reliable manner

    Product Sof’Bag®+ protects the formulation and delivers it on a reliable manner

    Sof’Bag®+, the airless solution for your sensitive formulations Sof’Bag®+ is an airless pouch-in-bottle technology allowing the formulation to be dispensed out of a collapsing pouch encased inside a rigid bottle upon pump actuation. Each actuation delivers a precise metered dose of formulation, which is di...
  • Symbioze(TM):  smart and sustainable on-body injector platform to improve patients’ injection experience

    Product Symbioze(TM): smart and sustainable on-body injector platform to improve patients’ injection experience

    Symbioze: fostering patient adherence with high-volume, multiple-use wearable. Symbioze is specifically tailored to administer complex drugs, such as biologic therapies, thanks to a highly engineered, reliable drug delivery system. It is suitable for large volumes such as 20ml and beyond, while preserving...
  • UniSpray: single-metered dose for systemic-acting drug administration

    Product UniSpray: single-metered dose for systemic-acting drug administration

    UniSpray: ideal systemic delivery for emergency lifesaving and crisis treatments UniSpray is a unidose system concept under development, designed to be robust and compatible with existing marketed primary container. Through usability analysis and Freedom to Operate assessment, we assure reliability and reg...

Nemera resources (22)

  • News Nemera: Stronger than ever

    More modern, our new brand identity truly embodies who we are, how we partner with our customers and ultimately the value we bring to millions of patients across the world through our drug delivery device solutions.
  • Video Innovation in Connectivity Roundtable pt.1

    The Innovation in Connectivity Roundtable originally aired as part of Pharmapack Europe 2021 Part 1 of this session includes three presentations: Patient Journey Driven Considerations for Integrating Digital Health for Combination Products The importance of utilizing applied ethnography and other primary research methods to understand the patient journey as the foundation for integrating digital health into a device/combination product development initiative. Considering patient needs in the context of a larger ecosystem including providers, payers, and regulators to develop a robust plan with respect to connectivity and digital health. Examples of how this understanding is applied across the combination product development journey through organic development, utilization of platform devices, or as a lifecycle management enchantments while optimizing the user experience resulting in safe, effective, and differentiated combination products. Mark Tunkel, Global Category Director for Insight Innovation, Nemera Electronic Product Information: A Case Study on Medicine Labelling for the Visually Impaired The Electronic Product Information Initiative for Medicines (ePI) aim to ease the accessibility of product information to everyone, including visually impaired patients. The GS1 Digital Link aim to provide a single barcode for identification, brand protection, and access to product information for patients. Our lecture will illustrate how the existing Datamatrix on packaging could be leveraged, today, by everyone, including visually impaired users, to access a tailored and relevant information. Laurent Tonnelier, CEO, mobiLead - xTag Lise Wagner, Accessibility Specialist and User Expert, OKEENEA Traceability of Medicines: from Finished Product to Unit Dose Delivery Challenges for B2B Supply Chain stakeholders Regulations: a global overview What about B2C Nathalie Wardé, CEO & Founder, D4P pharma Join the above speakers and moderator Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG for the live panel discussion that followed in the Innovation in Connectivity Roundtable pt. 2
  • News Pharmapack Europe 2021 announces Awards winners!

    Awards showcased a wide range of industry-changing innovations in packaging and drug delivery, with sustainability emerging as a key metric across all categories
  • Video Innovation in Connectivity Roundtable pt. 2

    The second part of the Innovation in Connectivity Roundtable brings together presenters from Nemera, D4P Pharma and xTag for a group discussion and live Q&A (45-minutes). Moderated by Lionel Jeannin, Group Head Oral Packaging & Delivery Systems, Novartis Pharma AG Participants: Mark Tunkel, Global Category Director for Insight Innovation, Nemera Laurent Tonnelier, CEO, mobiLead – xTag Lise Wagner, Accessibility Specialist and User Expert, OKEENEA Nathalie Wardé, CEO & Founder, D4P pharma This webinar originally aired as part of Pharmapack 2021
  • News Pharmapack 2021: Increasing connectivity is the key to patient centricity and simplified access to product information

    During the live Innovation in Connectivity Roundtable at the Pharmapack 2021 online conference, experts discussed how the latest innovations in digital technology are shaping industry ambitions to put the patient journey at the heart of its drug device and delivery solutions by simplifying product information via increased connectivity.
  • Video Welcome to the Digital Health & Connectivity & Patient-Centricity Track

    This webinar will address: Key market trends in digital health and how they have accelerated in the past years Nemera’s vision of digital health and the implications on the whole drug/device development ecosystem – how connectivity is creating incredible opportunities for the industry but also raises some challenges: link to conferences in the track How does Nemera play in this landscape: presentation of the company, our capabilities and some examples of our connected devices. Webinar originally aired as part of Pharmapack Europe 2021
  • News Considerations for device selection in parenteral applications.

    While patient centricity is the foundation for developing a robust device selection plan and completion of a successful combination product development initiative, developers need to remember there is a larger ecosystem that must be considered to ensure success.
  • Video Nemera: We Put Patients First

    As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint to market of their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission.
    For more information, visit www.nemera.net
  • News Nemera is excited to announce that its multidose eye dropper Novelia® has been approved in Brazil!

    Nemera is excited to announce that its multidose eye dropper Novelia® has been approved by ANVISA for the preservative-free formulations CLILON [1] (Ketorolac 0,4% and 0,5%), a nonsteroidal anti-inflammatory drug (NSAID) that is used to treat moderately severe pain and inflammation, usually after surgery.
  • Video NEMERA CEO SHARES 2021 AMBITION

    Our CEO, Marc Hämel shares the lessons we learned from last year, extends his wishes, gratitude to the Nemera family and walks us through the top company goals that will shape and drive our story in 2021!
  • News Nemera – an integrated CDMO and Own-IP player

    In this report, Alira Health in partnership with MassMEDIC analyzes the rapidly evolving DDD landscape and how industry leaders like Nemera strive to enhance the end-to-end services offering by integrating the pharmaceutical value chain.
  • Video Nemera at CPHI Worldwide 2019 - Bernhard Rohn and Mark Tunkel

    Our VP strategy and marketing and our director of business development, Insight Innovation Center are presenting Nemera and its portfolio. They are giving more details about Insight Innovation Center.
  • News The pivotal role played by device developers to improve patient eye care

    Our ophthalmic experts discuss the challenges glaucoma and dry eye patients face with eye drop administration and present the Novelia® system featuring patented PureFlow® technology, which controls the medication flow.
  • Video Nemera at CPHI Worldwide 2018

    Nemera, Juan Sarmien, Sales Director for North America at Nemera, speaks with CPHI TV at CPHI Worldwide in Madrid.
  • News Nemera breaks ground in Brazil through Milfra acquisition

    Nemera announced that they have entered into an agreement to acquire Milfra. Milfra, based in Jaguariuna, state of São Paulo, Brazil, specializes in the development and production of both vaginal and rectal applicators, as well as oral dosers for the pharmaceutical industry. A family-owned company f...
  • News Nemera expands its insulin pen’s offer in Brazil

    This partnership expands offer of diabetes medicines in the country; Nemera’s Advapen launch happens under the trade name Lifepen® for the administration of Glargilin insulin for the treatment of diabetes A pioneer in biotechnological medicines in Brazil, BIOMM is launching Nemera’s Advapen under the trade name Lifepen® for the administration of Glargilin insulin for the treatment of diabetes.
  • Video Nemera: Sronger Than Ever

    Our proven experience in the complementary activities surrounding drug delivery device and combination product development, alongside our strong know-how in our industry ecosystem, puts us in an optimal place to support our customers as partners through every step in their journey. By keeping the patient top of mind, we create success on all fronts. We aim to improve patients’ outcomes and build customer success. In order to do that, we have three key pillars that form the base of our organizational identity: • Patients first. Always. • Partnering in drug delivery devices. Holistically. • Going the extra mile. Together. Our new logo and a new brand style convey this message to customers, applicants, shareholders, and other stakeholders, with a fresh, friendly, and moving-forward look and feel.
  • News Nemera to acquire Copernicus to boost parenteral product portfolio and small series capabilities

    Nemera today announced that they have entered into an agreement to acquire Copernicus. Copernicus, based in Szczecin Poland, specializes in the development and manufacturing of injection devices. Their range of reusable and disposable pen injectors are tailored for the treatment of several chronic pathologies.


  • News Nemera and Noble collaboration for training on Safe’n’Sound® 2.25 ml

    As one of the world’s leading providers of design, development and manufacturing of drug delivery devices, we announced the conclusion of a collaboration agreement with Noble, global provider of medical device training solutions and patient onboarding strategies for the world’s top pharmaceutical and biotechnology brands. On this occasion, the latest issue of ‘The Pharmaceutical post’ publish an article about the collaboration between Nemera and Noble.
  • News NASAL SPRAY BIOEQUIVALENCE

    In the pharmaceutical industry, we can see the development of generics is significantly growing. This trend is mainly driven by countries to give patients easier access to drugs and to define regulations accordingly.
  • News RETRONOSE: IMPROVING NASAL DELIVERY THROUGH NEW AND IMPROVED DEVICE

    RetroNose is a completely new drug delivery concept to dispense drug formulation to the nasal cavity. The principle of this concept is to deliver a spray through the oral cavity to deposit the drug in the nasal cavity from rear to front. To avoid aerosol penetration in the lung and to ensure deposition efficacy, the aerosol drug is automatically delivered during the nasal expiratory phase.

Frequently Viewed Together

  • Product Biologic drug substance CDMO services

    From pre-clinical development to commercial supply, Patheon by Thermo Fisher Scientific is an industry leader in the development and manufacture of mammalian cell culture drug substances. Patheon offers biotech and pharmaceutical companies the ability to pursue opportunities around the globe with a fully i...
  • Product Needle Isolation Technology (NIT®)

    NIT® is a safety solution that eliminates the need for manual needle attachment in cartridge-based injections. It enables cartridges to be built into autoinjectors, supporting treatments beyond the 2.25 mL fill range and lyophilized drugs requiring dual-chamber containers. 
    Products built with NIT ...
  • Product Ypsomed Digital Health

    Ypsomed provides pharmaceutical companies with fully integrated digital solutions. Our platform combines connected injection devices with comprehensive digital patient tools. Our aim is to facilitate research and development, shorten market access timelines and improve commercial success of subcutaneo...
  • Product DataCollector - High performance IT Infrastructure for Manufacturing

    The plus10 DataCollector provides a high-performance data infrastructure for the acquisition and pre-processing of machine data from any source such as sensors, machine or robot controllers. Its simple configuration and implementation transforms machine data into Big Data and creates value through high-fre...
  • Product D-Flex Injection Pen

    D-Flex, the pen platform for subcutaneous self-injection. Bridging the gap between fixed and variable-dose pens, this innovative product also paves the way for connected commercial devices.
    • Just one pen for many needs: Disposable pen for fixed or multiple fixed dosages • The versatile solution: Allo...
  • Product Formulation Development

    Recipharm offer formulation development services for all dosage forms. We develop everything from simple formulations for early studies to more complex formulations suited for commercialisation.
  • Product Reusable pens: multiple use, same efficiency

    Ergonomic, market-proven reusable pen injectors Our spring-assisted reusable pens lower the force necessary to administer the dose for patient's ease-of-use. Thanks to its ergonomic design, patients can easily reach the trigger button for an enhanced injection experience. This platform offers a high range ...
  • Product Terumo Injection Filter Needle

    The Terumo Injection Filter Needle, for those working to improve safety, precision and customer experience, for injection into sensitive areas such as the vitreous. 

    Integrated 5μm mesh filter, 30G-12mm extra-thin wall cannula, 
    soft blister packaging for as...
  • Product HDPE Bottles

    We provide an unmatched combination of product offerings & packages, design & innovation capabilities to leverage new technology & patient insights, & manufacturing expertise in pharmaceutical packaging

    To make Berry a part of your Healthcare manufacturing process, plea...
  • Product Biolevox™ Tendon

    Biolevox™ HA Tendon is hyaluronic acid (HA) gel especially designed for intratendinous or peritendinous injection as a double application therapy in order to alleviate the ongoing inflammation process and further recovery of the tendon functionality. HA-based gel contains 32 mg of sodium hyaluronate in 2.0...
  • Product Hyal Forte

    • HA Viscosupplement Inj. • Composition: Sodium hyaluronate 20mg /2mL      • Indication: Osteoarthritis of knee and periarthritis of shoulder • Dosage and administration: Once a week, 3 weeks continuously in knee and shoulder joint • Remark: Leading product in Korea. (See the brochu...
  • Product BD Vystra™ Disposable Pen

    Confidence in dose delivery - BD Vystra™ Disposable Pen is an intuitive, high-quality and customizable pen injector designed to support therapies that require frequent, low-volume injections or variable dosing.  

    BD partners with you to develop self-injection systems ...
  • Product Walk in Cooling Cabinet.

    The Walk-In Cooling Cabinets / cold rooms are designed according to ICH guidelines, WHO, MCA and USFDA requirements to maintain uniform conditions. They are superior in airflow distribution, temperature control technology, cabinet construction and are manufactured as per cGMP regulations.
    Biggest Walk...
  • Product CDMO

    • Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY  • CYTOTOXIC API • EU GMP  • JGMP (Japan) • KGMP (Korea) • PIC/S
  • Product Datapen

    Datapen is a smart reusable injector pen adapted to chronic disease treatments and connected to a mobile app.

    The solution records each dose injected, with specific time and date, and send the information back to the smartphone via Bluetooth technology.

    Compatible ...
  • Product Tramadol HCl

    Grünenthal GmbH offers a selected range of products which includes Tramadol HCl, as API, bulk and/ or finished dosage form. Please contact us for more information.

  • Product Parenteral manufacturing

    Dedicated to manufacturing parenteral dosage forms, Alcami's Charleston, South Carolina site supports preclinical production through commercial launch and supply. This US- and EU-compliant and DEA-licensed sterile manufacturing facility is fully integrated with our Wilmington, North Carolina packaging and ...
  • Product ADAPTEK® TECHNOLOGY

    ADAPTEK® TECHNOLOGY is the general name for our 4 international patents and expertise in nanotechnology and controlled release systems.This is a transversal technology that allows to develop customized biopolymeric nanohydrogels, allowing the load with different API (drugs, vitamins, growth factors, etc.)....
  • Product Nitolic® head lice treatment

    NITOLIC® is a new generation of medical devices intended for the complete treatment of head lice infestations (Pediculus humanus capitis).

    Single application – 100% efficacy

    kills all active developmental stages of head lice

    kills lice eggs (nits)

    ...
  • Product Cefadroxil Capsules

    Jingxin Pharmaceutical offers a wide range of finished dosage forms products which includes cefadroxil capsules. It belongs to cephalosporin category. Contact us for more information.
  • Product VhentPeel® Flat packaging made of grid coated paper

    Our modular concept for grid coated paper includes:
    • medical grade paper: 60 / 80 / 100 g/m²
    • grid coating: 6 / 11 g/m²

    Features:
    • solvent free
    • seals to rigid films and PE based sealing layers
    • low – medium – high seal strength
    • opt...
  • Product INJECTABLES

    Requiring injectables.EU-GMP is a must.
    EU dossier is a must.
    Licensing and supply model or distributorship.
  • Product Springs and Stamped & Bent Parts for Inhalers

    We are experts in designing and manufacturing springs, stamping & bending parts, and assemblies for metered-dose inhalers (MDI), dry poder inhalers (DPI) and soft mist inhalers (SMI).

    • Compression Springs • Constant Force Springs • Contact Springs • Stamping & Bending
  • Product Zyfort

    Indications
    Neuralgia, polyneuritis, facial paresis, ischialgia, Vit. B deficiency

    Each ZYFORT ampoule contains:
    Thiamine HCl ……………100 mg
    Pyridoxine HCl ………….100 mg
    Cyanocobalamine …...5000 mcg

    Package : Box of 20 ampoules @ 3 ml

  • Product OSTENIL®

    OSTENIL® is a solution containing hyaluronic acid for injection into the joint cavity.
    OSTENIL® is indicated for the treatment of symptoms of osteoarthritis. It has been shown to reduce pain and stiffness in the affected joint and to improve joint function
    Pre-filled syringe to relieve pain in...
  • Product Disposable Liraglutide injection pen

    Product Name: Disposable Liraglutide injection penPrice(USD): 2.05
    The Logo and product colors can be customized
    Company:Shanghai Enjosim Medical Technology Co., Ltd
  • Product Basic (Standard) Large Volume Parenterals

    Basic (Standard) Large Volume Parenterals 

  • Product Injectables Technology Platform Brochure

    Your Expert Partner for Clinical & Commercial Sterile Injectable Drug Product Supply • Wide & balanced range of sterile injectable services, including capability for combining injectable drugs & devices (combination products) • Aseptic & Terminal Sterilization Fill & Finish Tech...
  • Product Gamma Irradiated Cleanroom Facemasks With Tyvek Side Extensions

    Gamma Irradiated, Extra Large Cleanroom Facemask with Tyvek® Side Extensions, Green or Blue, with Double Elastic Headbands and with or without Fog-Prevention Adhesive are made from an inner facing of soft cellulose material, an outer facing of spunbonded polypropylene and a 100% meltblown polypropylene med...
  • Product Azacitidine EVER Pharma

    Azacitidine is a cytotoxic hypomethylating chemical analogue of cytidine used in the treatment of myelodysplastic syndromes.

    Azacitidine EVER Pharma is available in both the standard 100 mg vial size and a new 150 mg vial size aligned to the most common patient doses to minimize waste...
  • Product Alimenta TPN bags: new line made with a special material which improves ...

    Nutriline is the standard EVA TPN bags line, while Alimenta is the new line made with a special material which improves the TPN bag features:- Transparency: Alimenta is manufactured with a transparent film which allows an easy inspection of the solution contained in the bag. - PH stability: contrary to ...
  • Product DOUBLE FOLD CAP - 29MM

    - CLOSURE MADE FOR PLASTIC I.V BOTTLES AND BAGS MADE FROM BFS AND         FFS TECHNOLOGY - MEDICAL GRADE RAW MATERIAL PP 
    - EASY BREAK OFF TWIN HEAD 
    - EXCELLENT WELDING 

  • Product Santoprene® thermoplastic vulcanizate (TPV)

    Santoprene® TPV is new to the Celanese portfolio, offering reliable TPV component solutions for medical and drug delivery devices and packaging.  Whether it is peace-of-mind ranging from supply security to regulatory requirements; durability that elevates a patient's experience; or resistance to harsh...
  • Product Injectable vials in molded glass - Clareo

    Clareo, the highest quality Type II premium injection vials Clareo, the highest quality Type II premium injection vials Clareo vials are made of Type II glass and offer a combination of homogeneous wall thickness with superior cosmetic qualities suitable for high value products. Available fro...
  • Product Naprod Antineoplastic Formulation Injectable & Oral Solid , Propofol, Ge...

    #Propofol
    #Gemcitabine
    #Imatinib
    #Bleomycin
    #Irrinotecane
    #Linalidomide
    #Dasatinib
    #Abiraterone


  • Product NORADRENALINE (NOREPINEPHRINE) USP 1MG/ML, 4ML AMPOULE

    NORADRENALINE (NOREPINEPHRINE) USP 1MG/ML, 4ML AMPOULE  Treatment of hyperdynamic shock secondary to sepsis. Second line inotrope for treatment of fluid-refractory hypotensive shock in the setting of low systemic vascular resistance (SVR).Circulatory failure in the setting of pulmonary hypert...
  • Product Hospital Products for USA and/or Canada

    Methapharm is your strategic partner to bring your hospital and specialty products to market in the USA and/or Canada.  Part of the ACIC Group,  Methapharm is focused on the acquisition, development, licensing, and promotion of hospital and specialty pharmaceutical products as well as products in...
  • Product Prefilled Syringes & Injection Devices - October 2023 - Issue 152

    Available now to read online at: https://www.ondrugdelivery.com Contents: An Autoinjector Revolution: Enhanced Global Manufacturing NetworksThrough Advanced Simulation Technologies SHL Medical Identifying and Overcoming the Challenges ofInjectable Combination Product Evolution Kindeva Interview – Acce...
  • Product Primary Packaging - Gx® prefillable syringes

    Prefillable glass syringes in bulk and "ready-to-fill" format, type 1 glass, filling volumes of 0.5 ml to 5.0 ml, luer cone and luer lock syringes, needle syringes, silicone-oil reduces Gx Baked-on RTF® syringes, metal-free Gx RTF® syringes, innovative syringe components, round and cut finger flange, most ...
  • Product IV Solutions

    Vioser provides a wide variety of pharmaceutical products and medical equipment which includes IV solutions. Contact us for more information.
  • Product Desibem

    Decitabine50 mg Powder for Solution for IV Injection
    10 ml Vial / Per Box 
  • Product PLATINOX for inj. (Oxaliplatin)


    Anti-cancer.

    It contains Oxaliplatin 50mg.

    Form:  Lyophilized.
  • Product Formulation Development Services

    Aurigene Pharmaceutical Services offers end-to-end formulation development services ranging from early development to clinical supplies for new chemical entities for the pharmaceutical, nutraceutical & animal healthcare industry along with life cycle extension of the products. We have the expertise alo...
  • Product MediTect™ IV Bags

    Designed to prevent extractables and leachables (E&L) from packaging material, these soft bags are the ideal option for more sensitive drug solutions.
    The most important thing to consider in primary packaging is "interaction factor." By using Cyclic Olefin Polymer, an extremely inert materi...
  • Product Kalceks Product List

    Full product portfolio
  • Product JOYDROPS LUBRICANT GELS-CHERRY

    Turkuaz medikal kozmetik dis ticaret ltd provides wide range of products which includes joydrops lubricant gels-cherry. Contact us for more informations.
  • Product Drug Product Fill-Finish Services

    Fill-Finish Capabilities (product type) and Capacity:
    Sterile liquid products
    Biosafety level (BSL) 1, BSL 2 (OEL >= 10 µg/m³)
    Vaccines (inactivated)
    Current capacity: ~40M units/year